Gad Getz

Gad Getz

Harvard University

H-index: 228

North America-United States

About Gad Getz

Gad Getz, With an exceptional h-index of 228 and a recent h-index of 197 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cancer Genomics, Computational Biology, Bioinformatics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Inferring early genetic progression in cancers with unobtainable premalignant disease

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

Gad Getz Information

University

Harvard University

Position

Massachusetts General Hospital and Broad Institute of Harvard and MIT

Citations(all)

342986

Citations(since 2020)

208304

Cited By

219935

hIndex(all)

228

hIndex(since 2020)

197

i10Index(all)

387

i10Index(since 2020)

368

Email

University Profile Page

Harvard University

Gad Getz Skills & Research Interests

Cancer Genomics

Computational Biology

Bioinformatics

Top articles of Gad Getz

Title

Journal

Author(s)

Publication Date

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Cancer Cell

Yize Li

Tung-Shing M Lih

Saravana M Dhanasekaran

Rahul Mannan

Lijun Chen

...

2023/1/9

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature genetics

Arvind Ravi

Matthew D Hellmann

Monica B Arniella

Mark Holton

Samuel S Freeman

...

2023/5

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

Blood

Jasneet Kaur Khalsa

Justin Cha

Filippo Utro

Aishath Naeem

Ishwarya Murali

...

2023/8/3

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Nature Medicine

Erin M Parry

Ignaty Leshchiner

Romain Guièze

Connor Johnson

Eugen Tausch

...

2023/1/9

Inferring early genetic progression in cancers with unobtainable premalignant disease

Nature Cancer

Ignaty Leshchiner

Edmund A Mroz

Justin Cha

Daniel Rosebrock

Oliver Spiro

...

2023/4

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

Cell

Yifat Geffen

Shankara Anand

Yo Akiyama

Tomer M Yaron

Yizhe Song

...

2023/8/31

Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy

Nature Cancer

Tim HH Coorens

Grace Collord

Taryn D Treger

Stuart Adams

Emily Mitchell

...

2023/8

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

Blood cancer discovery

Elisa Ten Hacken

Tomasz Sewastianik

Shanye Yin

Gabriela Brunsting Hoffmann

Michaela Gruber

...

2023/3/1

Polymorphic gene typing and somatic change detection using sequencing data

2023/8/15

IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

Blood Advances

Ferran Nadeu

Charlotte Syrykh

Berta Pons-Brun

Núria Russiñol

Heribert Playa-Albinyana

...

2023/7/28

Proteogenomic data and resources for pan-cancer analysis

Yize Li

Yongchao Dou

Felipe Da Veiga Leprevost

Yifat Geffen

Anna P Calinawan

...

2023/8/14

MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology

Cancer discovery

Ankit K Dutta

Jean-Baptiste Alberge

Elizabeth D Lightbody

Cody J Boehner

Andrew Dunford

...

2023/2/6

Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors

Clinical Cancer Research

Joseph Toker

J Bryan Iorgulescu

Alexander L Ling

Genaro R Villa

Josephina AMA Gadet

...

2023/6/13

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Nature

Hideko Isozaki

Ramin Sakhtemani

Ammal Abbasi

Naveed Nikpour

Marcello Stanzione

...

2023/8/10

The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia

Blood Advances

Clare Sun

Yun-Ching Chen

Aina Martinez Zurita

Maria Joao Baptista

Stefania Pittaluga

...

2023/1/10

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

Blood Advances

Aishath Naeem

Filippo Utro

Qing Wang

Justin Cha

Mauno Vihinen

...

2023/5/9

CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers

Science

Ruben Bill

Pratyaksha Wirapati

Marius Messemaker

Whijae Roh

Beatrice Zitti

...

2023/8/4

Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function

Science

Gökcen Eraslan

Eugene Drokhlyansky

Shankara Anand

Evgenij Fiskin

Ayshwarya Subramanian

...

2022/5/13

Multiple Myeloma With Amplification of Chr1q: Therapeutic Opportunity and Challenges

Romanos Sklavenitis-Pistofidis

Gad Getz

Irene Ghobrial

Maria Papaioannou

2022/7/14

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Nature genetics

Binyamin A Knisbacher

Ziao Lin

Cynthia K Hahn

Ferran Nadeu

Martí Duran-Ferrer

...

2022/11

See List of Professors in Gad Getz University(Harvard University)

Gad Getz FAQs

What is Gad Getz's h-index at Harvard University?

The h-index of Gad Getz has been 197 since 2020 and 228 in total.

What are Gad Getz's top articles?

The articles with the titles of

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Inferring early genetic progression in cancers with unobtainable premalignant disease

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

...

are the top articles of Gad Getz at Harvard University.

What are Gad Getz's research interests?

The research interests of Gad Getz are: Cancer Genomics, Computational Biology, Bioinformatics

What is Gad Getz's total number of citations?

Gad Getz has 342,986 citations in total.

What are the co-authors of Gad Getz?

The co-authors of Gad Getz are Stacey Gabriel, Todd Golub, Donna Neuberg, Wei Zhang PhD, Professor of Cancer Biology, Rameen Beroukhim, Michael S. Lawrence.

Co-Authors

H-index: 223
Stacey Gabriel

Stacey Gabriel

Harvard University

H-index: 186
Todd Golub

Todd Golub

Harvard University

H-index: 164
Donna Neuberg

Donna Neuberg

Harvard University

H-index: 157
Wei Zhang PhD, Professor of Cancer Biology

Wei Zhang PhD, Professor of Cancer Biology

Wake Forest University

H-index: 153
Rameen Beroukhim

Rameen Beroukhim

Harvard University

H-index: 138
Michael S. Lawrence

Michael S. Lawrence

Harvard University

academic-engine